Descrizione del progetto
Un esoscheletro accessibile permette la deambulazione
Gli esperti stanno sviluppando da tempo esoscheletri robotici per ripristinare i movimenti umani. Per diffondersi, gli esoscheletri devono diventare più accessibili da un punto di vista economico. I dispositivi attuali richiedono circa 100 000 EUR. ABLE Human Motion aspira a lanciare il primo esoscheletro accessibile e leggero in grado di aiutare chi è affetto da paralisi degli arti inferiori a ripristinare la capacità di camminare. ABLE si impegna a farlo in modo naturale e intuitivo, utilizzando un attuatore elettrico che flette ed estende la gamba, imitando il naturale movimento umano. Inoltre, viene utilizzato un sensore inerziale per rilevare l’intenzione dell’utente di fare un passo avanti. Questo sistema brevettato e rivoluzionario volto ad agevolare la deambulazione contribuisce ad attenuare i problemi di salute causati da uno stile di vita sedentario, aumentando al contempo la fiducia in se stessi e l’autonomia.
Obiettivo
People with lower-limb paralysis could walk again if they had a robotic exoskeleton to restore the leg movements affected by the injury. However, current devices are expensive (cost about 100 k€), heavy and require trained professional supervision. Therefore, they are only found in large hospitals and rehabilitation centers, and are out of the reach of the patient.
ABLE Human Motion is a medical device spin-off from Universitat Politècnica de Catalunya (UPC) that is developing and will commercialize robotic exoskeletons to enhance their mobility and independence. ABLE’s vision is to build a world where everybody has the possibility to move independently, with that aim we plan the launch of ABLE: the first home use, affordable and lightweight exoskeleton that restores the ability to walk of people with lower-limb paralysis in a natural and intuitive way. It is based on an electric actuator that flexes and extends the leg mimicking human natural movement, and an inertial sensor that together with dedicated algorithms detects the user’s intention to make the step forward. This patented and disruptive system to assist walking helps palliating health issues caused by sedentary lifestyle while boosting self-confidence and independence.
So far our newly established company has been awarded as an innovative technology to improve healthcare by CaixaImpulse and EIT Health. We have been selected among the 5 most promising medtech start-ups by MassMEDIC (Boston, USA). The team has also won the acceleration programs organized by Richi Foundation and CIMIT, the most successful health accelerator in the world. This has allowed us to validate the product-market fit with more than 150 stakeholders, establishing a viable business model and a go-to-market plan.
The project is currently at Technology Readiness Level (TRL) between 6 and 7, and should reach TRL9 within an 18-month timeframe.
Campo scientifico
- medical and health sciencesclinical medicinephysiotherapy
- social scienceseconomics and businessbusiness and managementbusiness models
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensors
- medical and health sciencesbasic medicineneurologystroke
- natural sciencescomputer and information sciencesartificial intelligencemachine learning
Programma(i)
Argomento(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-SMEInst-2018-2020-1
Meccanismo di finanziamento
SME-1 - SME instrument phase 1Coordinatore
08023 Barcelona
Spagna
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.